News

News
JNJ Press releases

Johnson & Johnson Innovation Announces Extension Of Innovation Partnering Office at Monash University In Collaboration With Victorian State Government To Accelerate The Life-Sciences Hub

Read full story
Other news

Ribon Therapeutics Secures $65 Million Financing

Read full story
Other news

Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

Read full story
Other news

POINT Biopharma Debuts as Publicly Traded Next-Generation Radiotherapeutics Company

Read full story
Other news

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story
Other news

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story
Other news

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story
JNJ Press releases

Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.

Read full story
JNJ Press releases

EUSA PHARMA ANNOUNCES ACQUISITION OF GLOBAL RIGHTS TO SYLVANT® (SILTUXIMAB) FROM JANSSEN SCIENCES IRELAND UC FOR $115 MILLION

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Memorandum of Understanding with Kyoto University to Collaborate in Identifying and Accelerating the Development of Innovative Healthcare Solutions

Read full story
JNJ Press releases

Bavarian Nordic Announces Agreement with Janssen for the Development of Vaccine Regimens against HIV-1 and Hepatitis B

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Finalists of Cognition Challenge

Read full story
JNJ Press releases

Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation

Read full story